Evidence map›Paper›PMID 41135771›Full record

ReviewBiological psychiatry2026

Postpartum Psychosis and Bipolar Disorder: Review of Neurobiology and Expert Consensus Statement on Classification.

Veerle Bergink, Schahram Akbarian, Nancy Byatt, Prabha S Chandra, Nicole Cirino, Paola Dazzan, Lot De Witte, Arianna Di Florio, Clare Dolman, Ian Jones and 11 more

Abstract readReview
In one paragraph

Review in Biological psychiatry, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

21 authors.

Veerle BerginkDepartment of Psychiatry, Icahn School of Medicine at Mount Sinai, New York, New York; Department of Psychiatry, Erasmus University Medical Center, Rotterdam, the Netherlands. Electronic address: Veerle.bergink@mssm.edu.
Schahram AkbarianDepartment of Psychiatry, Icahn School of Medicine at Mount Sinai, New York, New York.
Nancy ByattDepartments of Psychiatry and Behavioral Sciences, Obstetrics and Gynecology, and Population and Quantitative Health Sciences, UMass Chan Medical School/UMass Memorial Health, Worcester, Massachusetts.
Prabha S ChandraDepartment of Psychiatry, National Institute of Mental Health and Neuro Sciences, Bengaluru, India.
Nicole CirinoDepartment of Obstetrics and Gynecology and Menninger Department of Psychiatry and Behavioral Sciences, Baylor College of Medicine, Houston, Texas.
Paola DazzanDepartment of Psychological Medicine, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, United Kingdom.
Lot De WitteDepartment of Psychiatry, Icahn School of Medicine at Mount Sinai, New York, New York; Department of Human Genetics, Department of Psychiatry, Radboud University Medical Center, Nijmegen, the Netherlands.
Arianna Di FlorioDepartment of Psychological Medicine and Clinical Neuroscience, Cardiff University, Cardiff, United Kingdom.
Clare DolmanKing's Women's Mental Health, King's College London, London, United Kingdom.
Ian JonesNational Centre for Mental Health, Division of Psychiatry and Clinical Neurosciences, Cardiff University, Cardiff, United Kingdom.
Astrid KampermanDepartment of Psychiatry, Erasmus University Medical Center, Rotterdam, the Netherlands.
Behrang MahjaniDepartment of Psychiatry, Icahn School of Medicine at Mount Sinai, New York, New York.
Samantha Meltzer-BrodyDepartment of Psychiatry, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina.
Trine Munk-OlsenResearch Unit of Child and Adolescent Psychiatry, Department of Clinical Research, University of Southern Denmark, Odense, Denmark.
Sarah Nagle-YangDepartment of Psychiatry, University of Colorado School of Medicine, Aurora, Colorado.
Lauren M OsborneDepartment of Obstetrics and Gynecology and Department of Psychiatry, Weill Cornell Medical College, New York, New York.
Natalie RasgonDepartment of Psychiatry, Icahn School of Medicine at Mount Sinai, New York, New York; Department of Psychiatry, Stanford University Medical Center, Stanford, California.
Thalia RobakisDepartment of Psychiatry, Icahn School of Medicine at Mount Sinai, New York, New York.
Harish ThippeswamyDepartment of Psychiatry, National Institute of Mental Health and Neuro Sciences, Bengaluru, India.
Simone N VigodDepartment of Psychiatry, Temerty Faculty of Medicine, University of Toronto, Toronto, Ontario Canada; Department of Psychiatry, Women's College Hospital, Toronto, Ontario, Canada.
Jennifer L PayneDepartment of Psychiatry and Neurobehavioral Sciences, University of Virginia, Charlottesville, Virginia.

Funding

Relapse risk after Discontinuation of Antidepressants during Pregnancy (R-DAP study)R01MH122869 · NIMH · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI Veerle Bergink · 2020 to 2026
$4.3M
Developmental effects of antenatal exposure to antipsychoticsR01HD111117 · NICHD · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI THALIA K ROBAKIS · 2023 to 2026
$2.5M
Risk architecture of postpartum psychosisR21MH131933 · NIMH · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI MAHJANI, BEHRANG · 2023 to 2024
$465k
Epigenetic Biomarkers of Postpartum PsychosisR21MH134114 · NIMH · UNIVERSITY OF VIRGINIA · PI PAYNE, JENNIFER L · 2023 to 2023
$451k
NICHD NIH HHS R01 HD111117NIMH NIH HHS R01 MH122869NIMH NIH HHS R21 MH131933NIMH NIH HHS R21 MH134114
6 · The paper itself

Abstract

Postpartum psychosis (PP) is an acute and severe psychiatric illness with onset within weeks after delivery and a high risk of suicide and infanticide. Most women with PP experience severe mood symptoms, including mania, mixed episodes, or depression with psychotic features. Impaired cognition, irritability, and agitation are also common. The specific timing of PP strongly suggests a biological basis, because the postpartum time period is characterized by profound endocrine, immune, neuroanatomical, and physiological changes in the brain. Genetic studies show a unique risk architecture, partly shared with bipolar disorder. PP stands out as one of the most distinct clinical phenotypes in psychiatry due to its characteristic rapid onset, severity, phenomenology, treatment response, and prognosis. Despite this, as of August 2025, PP does not have a distinct diagnostic classification in the DSM. This expert consensus panel, in close collaboration with patient organizations and key interested partners, recommends classifying PP as a distinct category within DSM-5 and ICD-11. We recommend classification within the bipolar disorders chapter of the DSM because 1) most women with PP have prominent affective symptoms; 2) treatment response to lithium and electroconvulsive therapy is excellent; 3) in half of the cases, first-onset PP is also the first onset of bipolar disorder; 4) pregnant women with bipolar disorder are at very high risk of PP; and 5) the genetic risk architecture for PP is distinct but overlapping with bipolar disorder. This consensus statement summarizes scientific evidence that PP is a distinct mental illness within the bipolar spectrum; correct classification will improve detection and treatment.

Indexed as

Bipolar DisorderPostpartum PeriodPsychotic DisordersPuerperal DisordersConsensusDiagnostic and Statistical Manual of Mental DisordersFemaleHumansBipolar disorderDSM classificationGeneticsNeuroimagingPostpartum psychosisTreatment

Identifiers

PMID41135771
PMCPMC12673989

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.